SWP
GTBP icon

Sagespring Wealth Partners’s GT Biopharma GTBP Stock Holding History

Sagespring Wealth Partners’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.79K Buy
+20,000
New +$8.11K ﹤0.01% 846

Other funds holding GTBP

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
KP
Kitching Partners Conshohocken, Pennsylvania $116M AUM 16.12% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return
TWP
Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return

Sagespring Wealth Partners's GTBP Position: Q2 2026 in Review

Sagespring Wealth Partners opened a new position in GT Biopharma (GTBP) in Q2 2026: 20,000 shares worth $9.79K. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings.

19 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Sagespring Wealth Partners held 20,000 shares of GT Biopharma worth $9.79K as of Q2 2026.
  • GT Biopharma was a new Sagespring Wealth Partners position in Q2 2026.
  • GT Biopharma made up ﹤0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #846 holding.
  • 19 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.